特发性门静脉高压症预后及其影响因素*

doi:10.3969/j.issn.1672-5069.2018.03.004

Abstract

Yang Kaiqi, Chen Shiyao. Prognosis of patients with idiopathic portal hypertension[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 332-335.

[1] Schouten JN,Garcia-Pagan JC,Valla DC,et al.Idiopathic noncirrhotic portal hypertension. Hepatology,2011,54(3): 1071-1081.
[2] Eapen CE,Nightingale P,Hubscher SG,et al.Non-cirrhotic intrahepatic portal hypertension:associated gut diseases and prognostic factors. Dig Dis Sci,2011,56(1):227-235.
[3] Hillaire S,Bonte E,Denninger MH,et al.Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients. Gut,2002,51(2):275-280.
[4] Cazals-Hatem D,Hillaire S,Rudler M,et al.Obliterative portal venopathy:portal hypertension is not always present at diagnosis. J Hepatol,2011,54(3):455-461.
[5] Okuda K.Non-cirrhotic portal hypertension:why is it so common in India. J Gastroenterol Hepatol,2002,17(1):1-5.
[6] Sarin SK,Kapoor D.Non-cirrhotic portal fibrosis:current concepts and management. J Gastroenterol Hepatol,2002,17(5): 526-534.
[7] Siramolpiwat S,Seijo S,Miquel R,et al.Idiopathic portal hypertension:natural history and long-term outcome. Hepatology,2014,59(6):2276-2285.
[8] Schouten JN,Nevens F,Hansen B,et al.Idiopathic noncirrhotic portal hypertension is associated with poor survival:results of a long-term cohort study. Aliment Pharmacol Ther,2012,35(12): 1424-1433.
[9] Maruyama H,Kondo T,Sekimoto T,et al.Differential clinical impact of ascites in cirrhosis and idiopathic portal hypertension. Medicine (Baltimore),2015,94(26):e1056.
[10] Fujiyama S,Saitoh S,Kawamura Y,et al.Portal vein thrombosis in liver cirrhosis:incidence,management,and outcome. BMC Gastroenterol,2017,17(1):112.
[11] Matsutani S,Maruyama H,Akiike T,et al.Study of portal vein thrombosis in patients with idiopathic portal hypertension in Japan. Liver Int,2005,25(5):978-983.
[12] Chang PE,Miquel R,Blanco JL,et al.Idiopathic portal hypertension in patients with HIV infection treated with highly active antiretroviral therapy. Am J Gastroenterol,2009,104(7):1707-1714.
[13] Orozco H,Guraieb E,Takahashi T,et al.Deficiency of protein C in patients with portal vein thrombosis. Hepatology,1988,8(5):1110-1111.
[14] Valla DC,Condat B.Portal vein thrombosis in adults:pathophysiology,pathogenesis and management. J Hepatol,2000,32(5):865-871.
[15] Hirohata Y,Murata A,Abe S,et al.Portal vein thrombosis associated with antiphospholipid syndrome. J Gastroenterol,2001,36(8):574-578.

Prognosis of patients with idiopathic portal hypertension

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Zhu Yucheng, Yan Jiawei, Sun Jingkun, et al. Serum diamine oxidase level in patients with hepatitis B-induced acute-on-chronic liver failure [J]. Journal of Practical Hepatology, 2019, 22(5): 672-675.
[2]	Wang Gang, Zhao Hongbo, Zhu Yaling, et al. Cancerous XPO5 gene level in patients with hepatocellular carcinoma and its clinical significance [J]. Journal of Practical Hepatology, 2019, 22(5): 724-727.
[3]	Zhuang Taiping, Yin Yangyan, Xie Manfang, et al. Comparison of clinical features of infants with human cytomegalovirus infection and of infantile hepatitis syndrome [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 514-517.
[4]	Peng Silu, Liu Bing, Sun Hong, et al. Prognosis of patients with hepatitis B-induced acute-on-chronic liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 545-548.
[5]	Lu Ximei, Kang Yanfei, Song Zhiyong, et al. Application of color Doppler ultrasonography in the diagnosis of biliary complications in patients after liver transplantation [J]. Journal of Practical Hepatology, 2019, 22(4): 589-592.
[6]	Ma Xinkui, Liu Yong, Zhang Wei. Two-year follow up of patients with intrahepatic cholelithiasis after percutaneous transhepatic choledochoscopic lithotripsy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 593-596.
[7]	Zhang Tingting, Wang Xuan. Clinical implications of oral glucose tolerance test in cirrhotic patients with hepatogenous diabetes [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 449-452.
[8]	Gao Pengbin, Zhao Xiaoyan, Qin Hao, Wu Fengying, Zhang Haizhen, Wang Lin, Jia Huina, Li Shujuan. Risk factors for poor prognosis of patients with hepatitis E-induced liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 220-223.
[9]	Wang Huming, Fan Dongsheng, Xu Jie, Liu Xianfegn, Zhou Ning, Li Min, Bao Nana. Cancerous miRNA-30c levels affecting the survival of patients with hepatocellular carcinoma after hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 248-251.
[10]	Zhang Xiaozhou, Shuai Ling, Wang Qingda, Yang Nan. Changes of serum miR-335 levels in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 268-271.
[11]	Ma Deyuan, Ma Yuanfeng, Zhang Dianlong, et al.. Prognostic efficacy of serum keratin 18 in patients with hepatitis B virus-related acute on chronic liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 77-80.
[12]	Ma Lyuxiang, Zhang Xuesong.. Efficacy and prognosis of ultrasound-guided percutaneous radiofrequency ablation in treatment of patients with small hepatocellular carcinoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 125-128.
[13]	Yu Xutong, Jiang Xiuhua, Qi Tingting, et al.. Verification of bleeding criteria in patients with acute-on-chronic liver failure: A prospective study [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 885-889.
[14]	Hongjie, Zhou Dongfang.. Efficacy of entecavir and Chinese herbal medicine combination therapy in patients with hepatitis B-induced liver cirrhosis An [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 903-906.
[15]	Baoyan, Wang Yun, Xiang Xiaogang, et al.. Prognosis of patients with hepatocellular carcinoma and underlying hepatitis B An [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 924-927.